Table 9.
Biological activities predicted for Ophiorrhiza rugosa major compounds by PASS online.
| Compound Name | Biological Properties Predicted by Pass Online | Pa | Pi |
|---|---|---|---|
| Loliolide | Sugar-phosphatase inhibitor | 0.727 | 0.028 |
| Antibacterial | 0.418 | 0.026 | |
| Spasmolytic, urinary | 0.454 | 0.062 | |
| Anti-inflammatory | 0.416 | 0.088 | |
| Antiperistaltic | 0.345 | 0.018 | |
| Antihelmintic | 0.345 | 0.071 | |
| Ethyl linolenate | Lipid metabolism regulator | 0.951 | 0.003 |
| Anti-inflammatory | 0.826 | 0.005 | |
| Histamine release inhibitor | 0.523 | 0.028 | |
| Antiparasitic | 0.489 | 0.017 | |
| Antihelmintic | 0.488 | 0.019 | |
| Anti-inflammatory, intestinal | 0.438 | 0.015 | |
| Methyl linoleate | Lipid metabolism regulator | 0.881 | 0.004 |
| Antisecretoric | 0.781 | 0.005 | |
| Anti-inflammatory | 0.727 | 0.013 | |
| Reductant | 0.637 | 0.009 | |
| Antihelmintic (Nematodes) | 0.500 | 0.017 | |
| Anti-infective | 0.424 | 0.038 | |
| Erucamide | Sugar-phosphatase inhibitor | 0.828 | 0.012 |
| Anti-infective | 0.501 | 0.022 | |
| Prostaglandin E1 antagonist | 0.470 | 0.005 | |
| Anti-inflammatory, intestinal | 0.444 | 0.014 | |
| Albendazole monooxygenase inhibitor | 0.450 | 0.026 | |
| Antitoxic | 0.387 | 0.025 | |
| γ-Sitosterol | Antihypercholesterolemic | 0.977 | 0.001 |
| Antiviral (Influenza) | 0.686 | 0.006 | |
| Antiinflammatory | 0.572 | 0.038 | |
| Antiacne | 0.529 | 0.005 | |
| Antiprotozoal (Leishmania) | 0.316 | 0.091 | |
| Antibacterial | 0.282 | 0.067 | |
| 2-Palmitoylglycerol | Sugar-phosphatase inhibitor | 0.927 | 0.003 |
| Lipid metabolism regulator | 0.889 | 0.004 | |
| Antiinfective | 0.757 | 0.005 | |
| Anti-inflammatory, intestinal | 0.578 | 0.004 | |
| Histamine release inhibitor | 0.573 | 0.015 | |
| Antiprotozoal (Leishmania) | 0.560 | 0.018 | |
| Methyl palmitate | Anti-inflammatory, intestinal | 0.758 | 0.002 |
| Calcium channel (voltage-sensitive) activator | 0.637 | 0.014 | |
| Antihelmintic (Nematodes) | 0.619 | 0.005 | |
| Reductant | 0.523 | 0.020 | |
| Antimutagenic | 0.513 | 0.014 | |
| Antiprotozoal (Leishmania) | 0.442 | 0.035 | |
| Methyl stearate | GABA aminotransferase inhibitor | 0.820 | 0.003 |
| Anti-inflammatory, intestinal | 0.758 | 0.002 | |
| Lipid metabolism regulator | 0.740 | 0.009 | |
| Gastrin inhibitor | 0.716 | 0.004 | |
| Antihelmintic (Nematodes) | 0.619 | 0.005 | |
| Antinociceptive | 0.538 | 0.019 | |
| Neophytadiene | Carminative | 0.691 | 0.007 |
| Gastrin inhibitor | 0.641 | 0.012 | |
| Antiulcerative | 0.585 | 0.012 | |
| Histamine release inhibitor | 0.506 | 0.034 | |
| Antiprotozoal (Leishmania) | 0.460 | 0.031 | |
| Antiparasitic | 0.395 | 0.032 | |
| Phytol | Lipid metabolism regulator | 0.828 | 0.005 |
| Antiparasitic | 0.615 | 0.008 | |
| Antihelmintic | 0.605 | 0.004 | |
| Antiprotozoal (Leishmania) | 0.601 | 0.014 | |
| Histamine release inhibitor | 0.526 | 0.027 | |
| Spasmolytic | 0.506 | 0.027 | |
| Squalene | Sugar-phosphatase inhibitor | 0.854 | 0.009 |
| Gastrin inhibitor | 0.743 | 0.003 | |
| Anti-inflammatory | 0.699 | 0.016 | |
| Antiparasitic | 0.555 | 0.011 | |
| Histamine release inhibitor | 0.558 | 0.018 | |
| Antihelmintic | 0.538 | 0.005 | |
| Stigmasterol | Dermatologic | 0.809 | 0.004 |
| Antiacne | 0.552 | 0.004 | |
| Antiinflammatory | 0.541 | 0.045 | |
| Antiprotozoal (Leishmania) | 0.403 | 0.047 | |
| Antisecretoric | 0.367 | 0.068 | |
| Bone formation stimulant | 0.306 | 0.020 | |
| Vitamin E | Lipid peroxidase inhibitor | 0.978 | 0.002 |
| Anti-inflammatory | 0.830 | 0.005 | |
| Free radical scavenger | 0.783 | 0.003 | |
| Spasmolytic | 0.525 | 0.024 | |
| Histamine release inhibitor | 0.396 | 0.093 | |
| Anti-infective | 0.277 | 0.122 |
Pa = Probable activity; Pi = Probable inactivity.